Literature DB >> 1312133

Pharmacological characterization of endothelin-stimulated phosphoinositide breakdown and cytosolic free Ca2+ rise in rat C6 glioma cells.

W W Lin1, J G Kiang, D M Chuang.   

Abstract

Because increasing evidence indicates that glial cells are a target of endothelin, we have characterized endothelin-induced phosphoinositide (PI) turnover and Ca2+ homeostasis in C6 glioma cells. Endothelin-1 (ET) increased formation of 3H-inositol phosphate (IP) from PI and elicited an increase in cytosolic free Ca2+ ([Ca2+]i) in rat C6 glioma. In the presence of Li+, the increase in 3H-inositol trisphosphate formation was rapid, reaching its peak at 5 min after stimulation. ET also elicited a rapid and sustained increase in [Ca2+]i in a dose-dependent manner (1-100 nM). The rank orders of efficacy for ET-related peptides in increasing [Ca2+]i were ET = ET-2 greater than sarafotoxin greater than ET-3. Both ET-mediated stimulation of IP formation and [Ca2+]i increase were largely inhibited in the absence of external Ca2+ but unaffected by the depletion of external Na+ and the presence of dihydropyridine derivatives or verapamil. Inorganic Ca2+ channel blockers Cd2+, La3+, and Mn2+ at 1 mM inhibited both responses induced by ET. Cross-desensitization and nonadditivity were observed for both events among ET-related peptides tested, but not between ET and ATP. Pretreatment of cells with pertussis toxin (PTX) attenuated the PI response to ET, but had no effect on ET-elicited [Ca2+]i increase. ET-induced Ca2+ mobilization (measured in Ca(2+)-free medium) was only transient and was inhibited by 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate. Moreover, the intracellular Ca2+ pools mobilized by ET and ATP appeared to overlap, as indicated by their partial heterologous desensitization.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312133      PMCID: PMC6576049     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  8 in total

1.  Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

2.  Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

3.  High concentrations of tricyclic antidepressants increase intracellular Ca2+ in cultured neural cells.

Authors:  P G Joshi; A Singh; B Ravichandra
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

4.  Opioids inhibit endothelin-mediated DNA synthesis, phosphoinositide turnover, and Ca2+ mobilization in rat C6 glioma cells.

Authors:  J Barg; M M Belcheva; R Zimlichman; R Levy; D Saya; R J McHale; F E Johnson; C J Coscia; Z Vogel
Journal:  J Neurosci       Date:  1994-10       Impact factor: 6.167

5.  Extracellular ATP stimulates inositol phospholipid turnover and calcium influx in C6 glioma cells.

Authors:  W W Lin; D M Chuang
Journal:  Neurochem Res       Date:  1993-06       Impact factor: 3.996

6.  Endogenous expression of histamine H1 receptors functionally coupled to phosphoinositide hydrolysis in C6 glioma cells: regulation by cyclic AMP.

Authors:  M C Peakman; S J Hill
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  Endothelin-1 induced desensitization in primary afferent neurons.

Authors:  Terika P Smith; Sherika N Smith; Sarah M Sweitzer
Journal:  Neurosci Lett       Date:  2014-09-08       Impact factor: 3.046

8.  FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.

Authors:  Y Leng; Z Wang; L-K Tsai; P Leeds; E B Fessler; J Wang; D-M Chuang
Journal:  Mol Psychiatry       Date:  2014-01-28       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.